Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BM32 in grass pollen allergy
NCT01538979Phase 2Completed
- Sponsor
- Biomay AG
- Start
- Mar 2012
- Primary completion
- Dec 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 6
01
Overview
A Phase 2 trial of BM32 in allergic rhinitis due to grass pollen, sponsored by Biomay AG. Started Mar 2012; status: completed.
02
Drugs
BM32
03
Conditions
allergic rhinitis due to grass pollen
Beyond the preview
Go deeper on NCT01538979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01538979.